等待开盘 12-29 09:30:00 美东时间
+0.410
+11.68%
Preliminary Phase 2 data demonstrate PCS6422+Capecitabine increased cancer-killing metabolite exposure while maintaining comparable safety to monotherapy capecitabineCompany on track to conduct formal interim analysis in
12-17 21:06
On December 12, 2025, Processa Pharmaceuticals, Inc. (the "Company") filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the "Certificate of Amendment") to the Company's Fourth Amended
12-16 00:07
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies and innovative treatments for rare diseases, today announced that its
11-05 22:16
Gainers Replimune Group (NASDAQ:REPL) stock increased by 95.3% to $8.79 during...
10-20 20:08
Gainers Bluejay Diagnostics (NASDAQ:BJDX) shares rose 113.4% to $3.99 during T...
10-09 20:07
Processa Pharmaceuticals shares are trading higher. The stock has recently gain...
10-09 00:56
Processa Pharmaceuticals shares jumped 37.5% after hours following a strong regular session, despite facing significant losses over the past year.
10-08 15:40
Shares of Telomir Pharmaceuticals Inc (NASDAQ:TELO) rose sharply in pre-market ...
10-07 17:28
Processa Pharmaceuticals ( ($PCSA) ) has issued an announcement. On September 2...
09-10 22:59
Processa Pharmaceuticals ( ($PCSA) ) has shared an announcement. On September 2...
09-03 05:27